Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.602, 2010-01, pp. : 1-1
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Ramipril `highly cost-effective' in Sweden
Inpharma, Vol. 1, Iss. 1342, 2002-01 ,pp. :
Alteplase cost-effective option for acute ischaemic stroke
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 333, 2001-01 ,pp. :
CRT a cost-effective option in Scandinavian settings
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 568, 2008-01 ,pp. :
Ezetimibe cost-effective option in statin intolerance
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 571, 2009-01 ,pp. :
Eptifibatide cost-effective option for coronary interventions
Inpharma, Vol. 1, Iss. 1310, 2001-01 ,pp. :